Effects of a Sugar-Based Synbiotic Product on Cardiometabolic and Intestinal Health (SUGAR-SYN BC3O) | MicrobiomeTrials← Back to trialsNCT07806383
Effects of a Sugar-Based Synbiotic Product on Cardiometabolic and Intestinal Health (SUGAR-SYN BC3O)
ENROLLING_BY_INVITATIONNAINTERVENTIONAL
Trial Details
Start: 2026-05-04Est. Completion: 2026-12-01
Enrollment target: 20 participants Locations- Federico II University, Naples, Italy
Other microbiome trials you might be interested in
UltrasonographyAirway ManagementIntubation, IntratrachealObesity and Overweight
Obese patients are at increased risk of difficult airway management due to anatomical changes in the anterior neck soft …
Multiple LocationsEst. completion Oct 20, 2026
Obesity (Disorder)
This randomized crossover clinical trial aims to evaluate the effect of a synbiotic containing Lactobacillus acidophilus…
Huixquilucan, MexicoEst. completion Feb 2, 2027
Recruiting
Overweight and Obese Adults
Obesity is a complex disease and a major risk factor for cardiovascular and metabolic disorders, particularly atheroscle…
Istanbul, Turkey (Türkiye)Est. completion Sep 30, 2026